Vanda Pharmaceuticals

This study aimed to evaluate the long-term safety and effectiveness of an investigational drug called imsidolimab for adults with generalized pustular psoriasis, a severe and painful skin condition. It was an extension of a previous trial, following participants who had already r…

This study tested whether an investigational drug called imsidolimab could safely reduce the severity of ichthyosis, a condition that causes widespread, thick, scaly skin. It was a Phase 2 trial where some participants received the drug and others received a placebo. The trial wa…

This study tested a drug called imsidolimab to see if it could reduce a painful, acne-like skin rash that is a common side effect of certain cancer treatments. It involved a small group of cancer patients who developed this rash while taking specific targeted therapies. The goal …